Herrera GFJ

Language: Spanish
References: 9
Page: s24-28
PDF size: 160.30 Kb.

REFERENCES

1. Rodríguez-Frias F, Jardi R, Buti M. Hepatitis E: virología molecular, epidemiología y patogénesis. Enferm Infecc Microbiol Clin. 2012; 30 (10): 624-634.

2. Nelson KE. Transmission of hepatitis E virus by transfusion: what is the risk? Transfusion. 2014; 54 (1): 8-10.

3. Marano G, Vaglio S, Pupella S, Facco G, Bianchi M, Calizzani G et al. Hepatitis E: an old infection with new implications. Blood Transfus. 2015; 13 (1): 6-17.

4. Petrik J. Hepatitis E international forum. Vox Sanguinis. 2015. doi: 10.111/Vox.12285.

5. Bi H, Yang R, Wu C, Xia J. Hepatitis E virus and blood transfusion safety. Epidemiol Infect. 2020; 148: e158.

6. Pisano MB, Mirazo S, Re VE. Hepatitis E virus infection: is it really a problem in Latin America? Clin Liver Dis (Hoboken). 2020; 16 (3): 108-113.

7. Cheung CKM, Wong SH, Law AWH, Law MF. Transfusion-transmitted hepatitis E: what we know so far? World J Gastroenterol. 2022; 28 (1): 47-75.

8. Viera-Segura O, Calderón-Flores A, Batún-Alfaro JA, Fierro NA. Tracing the history of hepatitis E virus infection in mexico: from the enigmatic genotype 2 to the current disease situation. Viruses. 2023; 15 (9): 1911.

9. Tanaka A, Matsubayashi K, Odajima T, Sakata H, Iida J, Kai K et al. Universal nucleic acid donor screening revealed epidemiological features of hepatitis E and prevented transfusion-transmitted infection in Japan. Transfusion. 2024; 64 (2): 335-347.